Bed Bath & Beyond (BBBY) PT Raised to $18 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Guggenheim Reiterates Neutral Rating on Bed Bath & Beyond (BBBY)
April 11, 2019 7:28 AM EDTGuggenheim analyst, Steven Forbes, reiterated a Neutral rating on Bed Bath & Beyond (NASDAQ: BBBY) following the company's 4Q report. BBBY's 4Q 2018 operating results (revenue, EBIT, and EPS) were essentially in-line with expectations. That said, retail comps fell ~5% year-over-year and EBIT margin eroded ~260 basis... More



